Clinical trial
The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
NCT01165983 is registered in ClinicalTrials.gov with Beth Israel Deaconess Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Aliskiren on Endothelial Function in Pre-Diabetes and Diabetes
- Lead sponsor
- Beth Israel Deaconess Medical Center
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2009
- Completion date
- Not reported
- Enrollment
- 124 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes type 2